Abstract:Nuclear factor–B (NF-B) plays a central role in inflammatory responses, and its physiologic functions are essential for cell survival and proliferation. Currently, drugs targeting NF-B inhibition have not yet been applied in clinical practice. We investigated the physiologic effect of a novel NF-B inhibitory compound, 1 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivative (INH #1), on three inflammatory animal models. The pharmacokinetics were measured by liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. Acute hepatitis was induced by administrating lipopolysaccharide (LPS) and D-(+)-galactosamine hydrochloride followed by the analysis of survival time and inflammatory mediators. Collagen-induced arthritis (CIA) was induced by immunization with type II collagen (CII), and serum-transfer arthritis (STA) was caused by injecting K/BxN mice serum. Clinical and histologic scores were evaluated in both arthritis models. Immune cell subset analysis, CII-induced interferon-gamma (IFN-) production and proliferation, and measurement of anti-CII IgG antibodies were performed in the CIA model. In the acute hepatitis model, INH #1 suppressed tumor necrosis factor- α (TNF- α ) production and prevented early death in a dose-dependent manner. INH #1 significantly attenuated arthritis scores and joint inflammation in both arthritis models. Additionally, in the CIA model, dendritic cells (DCs) in the regional lymph nodes were decreased in the treated mice and antigen-induced IFN- production and cell proliferation in splenocytes were inhibited, whereas the titers of anti-CII IgG antibodies were comparable regardless of the treatment. Here we revealed that INH #1 exerted anti-inflammatory effects in vivo via inhibition of inflammatory mediators and suppression of cellular immune responses. This compound could be a novel candidate for inhibition of NF-B in certain inflammatory diseases. SIGNIFICANCE STATEMENT A novel nuclear factor–B (NF-B) inhibitory compound, 1 H -pyrazolo[3,4- d ]pyrimidin-4-amine derivative (INH #1), which retains physiologically essential NF-B bioactivity, suppressed inflammation in three different mouse models: the acute hepatitis model, the collagen-induced arthritis model, and the K/BxN serum-transfer arthritis model. These results suggest that this compound could be a novel and potent anti-inflammatory agent.

New Dihydropyridine Derivative Attenuates NF-κB Activation Via Suppression of Calcium Influx in a Mouse BV-2 Microglial Cell Line

Anti-Inflammatory Effects of a Novel Nuclear Factor-{kappa}B Inhibitory Derivative Derived from PyrazoloPyrimidine in Three Inflammation Models

High-throughput screening and in vitro evaluation of CSB-0914; a novel small molecule NF-κB inhibitor attenuating inflammatory responses through NF-κB, Nrf2 and HO-1 cross-talk

Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway

The Anti-Inflammatory Activities of Benzylideneacetophenone Derivatives in LPS Stimulated BV2 Microglia Cells and Mice

Dihydro-CDDO-trifluoroethyl Amide Suppresses Inflammatory Responses in Macrophages Via Activation of Nrf2

NMDA receptor inhibitor MK801 alleviated pro-inflammatory polarization of BV-2 microglia cells

Discovery of an Effective Anti-Inflammatory Agent for Inhibiting the Activation of NF-κB

Design, Synthesis and Evaluation of a Series of Non-Steroidal Anti-Inflammatory Drug Conjugates As Novel Neuroinflammatory Inhibitors

2-Cyclohexylamino-5,8-dimethoxy-1,4-naphthoquinone Inhibits LPS-induced BV2 Microglial Activation Through MAPK/NF-kB Signaling Pathways

Natural Compounds Oridonin and Shikonin Exhibit Potentially Beneficial Regulatory Effects on Select Functions of Microglia

IMM-H004, a Novel Coumarin Derivative Compound, Attenuates the Production of Inflammatory Mediatory Mediators in Lipopolysaccharide-Activated BV2 Microglia

N-Salicyloyl Tryptamine Derivatives as Potent Neuroinflammation Inhibitors by Constraining Microglia Activation via a STAT3 Pathway

A novel glucosamine derivative exerts anti-inflammatory actions via inhibition of nuclear factor-kappaB

A Novel Pyrazole-Containing Indolizine Derivative Suppresses NF-κB Activation and Protects Against TNBS-induced Colitis Via a PPAR-γ-dependent Pathway

Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.

Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways

The Anti-inflammatory Effects of 4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic Acid in Lipopolysaccharide-Activated Primary Microglial Cells

Dalesconols B Inhibits Lipopolysaccharide Induced Inflammation and Suppresses NF-κB and P38/jnk Activation in Microglial Cells

1,10-Seco-eudesmane Sesquiterpenoids As a New Type of Anti-Neuroinflammatory Agents by Suppressing TLR4/NF-κB/MAPK Pathways

A Peptide Derived from IKK-Interacting Protein Attenuates NF-κB Activation and Inflammation.